Charles River Laboratories | CRL - Ebitda





Ebitda Изменить Дата
Agilent USD 577M 77M 2026-06
Align Technology USD 232.86M 3.72M 2026-06
Bio-Rad Laboratories USD 119.9M 475.4M 2026-09
Bruker USD 143.2M 33.2M 2026-06
Cardinal Health USD 955M 135M 2026-06
Charles River Laboratories USD 298.04M 25.1M 2026-09
Cigna USD 3.27B 9M 2026-06
CVS Health USD 4.9B 951M 2026-09
Danaher USD 2.1B 257M 2026-09
Dentsply International USD 146M 44M 2026-09
Elevance Health USD 2.67B 1.54B 2026-09
Humana USD 2.06B 2.35B 2026-03
Illumina USD 330M 80M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Intrexon USD -24.7M 2.92M 2024-06
IQVIA Holdings USD 1.03B 38M 2026-09
Laboratory Of America USD 674.3M 93.4M 2026-09
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Lonza CHF 1.01B 54M 2025-12
McKesson USD 1.97B 262M 2026-09
Merck EUR 1.6B 69M 2026-06
Mettler Toledo International USD 366.1M 43.45M 2026-09
Novartis USD 8.62B 2.14B 2026-09
Pfizer USD 6.36B 350M 2026-09
Quest Diagnostics USD 627M 21M 2026-09
Revvity USD 227.55M 629K 2026-09
Thermo Fisher Scientific USD 3.79B 244M 2026-09
United Therapeutics USD 334.2M 20.8M 2026-09
UnitedHealth USD 9.43B 567M 2026-06
Veradigm USD 38.81M 29.61M 2022-09
Waters USD 554M 158M 2026-09
West Pharmaceutical Services USD 267.4M 23.8M 2026-09